N-MOmentum - study design for a placebo-controlled study of MEDI-551 in neuromyelitis optica

被引：0

作者：

Cree, B. A. C. ^{[1
]}

Bennett, J. L. ^{[2
]}

Hartung, H. -P. ^{[3
]}

Aktas, O. ^{[3
]}

Kim, H. J. ^{[4
,5
]}

Paul, F. ^{[6
]}

Pittock, S. ^{[7
]}

Weinshenker, B. ^{[7
]}

Wingerchuk, D. ^{[8
]}

Marignier, R. ^{[9
]}

Fujihara, K. ^{[10
]}

Cutter, G. ^{[11
]}

Flor, A. ^{[12
]}

Barron, G. ^{[13
]}

Patra, K. ^{[12
]}

Madani, S. ^{[12
]}

Katz, E. ^{[13
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Univ Colorado, Denver, CO 80202 USA

[3] Univ Dusseldorf, Dusseldorf, Germany

[4] Res Inst, Seoul, South Korea

[5] Natl Canc Ctr Hosp, Seoul, South Korea

[6] Charite, D-13353 Berlin, Germany

[7] Mayo Clin, Rochester, MN USA

[8] Mayo Clin, Scottsdale, AZ USA

[9] Lyon Univ Hosp, Lyon, France

[10] Tohoku Univ, Sendai, Miyagi 980, Japan

[11] Univ Alabama Birmingham, Birmingham, AL USA

[12] MedImmune, Gaithersburg, MD USA

[13] MedImmune, Cambridge, England

来源：

MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1349

引用

页码：705 / 706

页数：2

共 50 条

[1] Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Cree, Bruce A. C.
Bennett, Jeffrey L.
Sheehan, Mark
Cohen, Jeffrey
Hartung, Hans-Peter
Aktas, Orhan
Kim, Ho Jin
Paul, Friedemann
Pittock, Sean
Weinshenker, Brian
Wingerchuk, Dean
Fujihara, Kazuo
Cutter, Gary
Patra, Kaushik
Flor, Armando
Barron, Gerard
Madani, Soraya
Ratchford, John N.
Katz, Eliezer
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (07) : 862 - 872
[2] Sensitivity analyses of time to adjudicated attacks in the N-MOmentum study, a randomised, placebo-controlled, double-masked trial in patients with neuromyelitis optica spectrum disorder
Cree, B. A. C.
Bennett, J. L.
Kim, H. J.
Weinshenker, B.
Pittock, S. J.
Wingerchuk, D.
Fujihara, K.
Paul, F.
Cutter, G.
Marignier, R.
Green, A.
Aktas, O.
Hartung, H. -P.
Lublin, F. D.
Mealy, M. A.
Drappa, J.
Barron, G.
Madani, S.
She, D.
Cimbora, D.
Rees, W.
Ratchford, J. N.
Katz, E.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 928 - 929
[3] The N-MOmentum study - a randomised, placebo-controlled, double-blind trial of Inebilizumab for neuromyelitis optica spectrum disorder: randomised controlled period and open-label extension results
Cree, B.
Bennett, J.
Kim, H. J.
Weinshenker, B.
Pittock, S.
Wingerchuk, D.
Fujihara, K.
Paul, F.
Cutter, G.
Marignier, R.
Green, A.
Aktas, O.
Hartung, H. -P.
Lublin, F.
Mealy, M.
Drappa, J.
Barron, G.
Madani, S.
Shi, D.
Cimbora, D.
Rees, W.
Ratchford, J.
Katz, E.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 42 - 44
[4] Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Cree, Bruce A. C.
Bennett, Jeffrey L.
Kim, Ho Jin
Weinshenker, Brian G.
Pittock, Sean J.
Wingerchuk, Dean M.
Fujihara, Kazuo
Paul, Friedemann
Cutter, Gary R.
Marignier, Romain
Green, Ari J.
Aktas, Orhan
Hartung, Hans-Peter
Lublin, Fred D.
Drappa, Jorn
Barron, Gerard
Madani, Soraya
Ratchford, John N.
She, Dewei
Cimbora, Daniel
Katz, Eliezer
Shuey, Neil
Milanov, Ivan
Kaprelyan, Ara
Tarnev, Ivaylo
Haralanov, Lyubomir
Carruthers, Robert
Munoz, Mario
Quinones, Jairo
Vargas, Jose
Rodriguez, Jesus
Nytrova, Petra
Vachova, Marta
Mares, Jan
Haldre, Sulev
Gross-Paju, Katrin
Ziemssen, Tjalf
Zettl, Uwe Klaus
Klotz, Luisa
Bergh, Florian Then
Lau, Alexander
Dioszeghy, Peter
Satori, Maria
Vecsei, Laszlo
Achiron, Anat
Karni, Arnon
Vaknin-Dembinsky, Adi
Saida, Takahiko
Misu, Tatsuro
Baba, Masayuki
LANCET, 2019, 394 (10206): : 1352 - 1363
[5] Inebilizumab prevents neuromyelitis optica spectrum disorder disability: outcomes from the N-MOmentum randomised, placebo-controlled, double-masked trial
Marignier, R.
Bennett, J. L.
Kim, H. J.
Weinshenker, B.
Pittock, S. J.
Wingerchuk, D.
Fujihara, K.
Paul, F.
Cutter, G.
Green, A.
Aktas, O.
Hartung, H. -P.
Lublin, F. D.
Mealy, M. A.
Drappa, J.
Barron, G.
Madani, S.
She, D.
Cimbora, D.
Rees, W.
Ratchford, J. N.
Katz, E.
Cree, B. A. C.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 896 - 898
[6] Diagnosis, Severity and Recovery of Attacks in the N-MOmentum Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
Paul, F.
Weinshenker, B. G.
Wingerchuk, D.
Green, A.
Bennett, J. L.
Kim, H. J.
Pittock, S.
Fujihara, K.
Cutter, G.
Marignier, R.
Aktas, O.
Hartung, H-P
Drappa, J.
Barron, G.
Madani, S.
Ratchford, J. N.
She, D.
Cimbora, D.
Katz, E.
Cree, B. A. C.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP80 - NP82
[7] Diagnosis, severity, and recovery of attacks in the N-MOmentum study of inebilizumab in Neuromyelitis optica spectrum disorder
Weinshenker, B.
Wingerchuk, D.
Green, A.
Bennett, J.
Kim, H. J.
Pittock, S.
Fujihara, K.
Paul, F.
Cutter, G.
Marignier, R.
Aktas, O.
Hartung, H. -P.
Drappa, J.
Barron, G.
Madani, S.
Ratchford, J.
Shi, D.
Cimbora, D.
Katz, E.
Cree, B.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 137 - 138
[8] The N-MOmentum Study-A Randomised, Placebo-Controlled, Double-Blind Trial of Inebilizumabfor Neuromyelitis Optica Spectrum Disorder: Randomised Controlled Period and Open-label Extension Results
Kim, H. J.
Bennett, J. L.
Weinshenker, B.
Pittock, S. J.
Wingerchuk, D.
Fujihara, K.
Paul, F.
Cutter, G.
Marignier, R.
Green, A.
Aktas, O.
Hartung, H-P
Lublin, F. D.
Mealy, M. A.
Drappa, J.
Barron, G.
Madani, S.
She, D.
Cimbora, D.
Rees, W.
Ratchford, J. N.
Katz, E.
Cree, B. A. C.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP37 - NP38
[9] Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study
Fujihara, Kazuo
Kim, Ho Jin
Saida, Takahiko
Misu, Tatsuro
Nagano, Yoshito
Totsuka, Naoko
Iizuka, Masato
Kido, Shinsuke
Terata, Ryuuji
Okumura, Kyoko
Hirota, Shinya
Cree, Bruce A. C.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
[10] Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
Marignier, Romain
Bennett, Jeffrey L.
Kim, Ho Jin
Weinshenker, Brian G.
Pittock, Sean J.
Wingerchuk, Dean
Fujihara, Kazuko
Paul, Friedemann
Cutter, Gary R.
Green, Ari J.
Aktas, Orhan
Hartung, Hans-Peter
Lublin, Fred D.
Williams, Ian M.
Drappa, Jorn
She, Dewei
Cimbora, Daniel
Rees, William
Smith, Michael
Ratchford, John N.
Katz, Eliezer
Cree, Bruce A. C.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):

← 1 2 3 4 5 →